Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04185194Phase 1Completed
Phase 1, randomised, open-label trial of lidocaine in myofascial pain syndrome (MPS) (3 arms), sponsored by Cairo University. Primary endpoint: Interleukin 6 at 3 months. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04185194.